Literature DB >> 23441041

Mitochondria as a pharmacological target: magnum overview.

Anna Olszewska1, Adam Szewczyk.   

Abstract

Mitochondria, responsible for energy metabolism within the cell, act as signaling organelles. Mitochondrial dysfunction may lead to cell death and oxidative stress and may disturb calcium metabolism. Additionally, mitochondria play a pivotal role in cardioprotective phenomena and a variety of neurodegenerative disorders ranging from Parkinson's to Alzheimer's disease. Mitochondrial DNA mutations may lead to impaired respiration. Hence, targeting the mitochondria with drugs offers great potential for new therapeutic approaches. The purpose of this overview is to present the recent state of knowledge concerning the interactions of various substances with mitochondria.
Copyright © 2013 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23441041     DOI: 10.1002/iub.1147

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  22 in total

Review 1.  Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway.

Authors:  Annalisa Marcuzzi; Elisa Piscianz; Claudia Loganes; Liza Vecchi Brumatti; Alessandra Knowles; Sabrine Bilel; Alberto Tommasini; Roberta Bortul; Marina Zweyer
Journal:  Int J Mol Sci       Date:  2015-12-30       Impact factor: 5.923

2.  Development and characterization of mitochondrial membrane affinity chromatography columns derived from skeletal muscle and platelets for the study of mitochondrial transmembrane proteins.

Authors:  Nagendra Surendra Singh; Kaia-Liisa Habicht; Ruin Moaddel; Ruth Shimmo
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2017-04-13       Impact factor: 3.205

3.  Intracellular localization of polymyxins in human alveolar epithelial cells.

Authors:  Maizbha U Ahmed; Tony Velkov; Qi Tony Zhou; Alex J Fulcher; Judy Callaghan; Fanfan Zhou; Kim Chan; Mohammad A K Azad; Jian Li
Journal:  J Antimicrob Chemother       Date:  2019-01-01       Impact factor: 5.790

4.  Poisoning of mitochondrial topoisomerase I by lamellarin D.

Authors:  Salim Khiati; Yeonee Seol; Keli Agama; Ilaria Dalla Rosa; Surbhi Agrawal; Katherine Fesen; Hongliang Zhang; Keir C Neuman; Yves Pommier
Journal:  Mol Pharmacol       Date:  2014-06-02       Impact factor: 4.436

5.  Epoxy-α-lapachone has in vitro and in vivo anti-leishmania (Leishmania) amazonensis effects and inhibits serine proteinase activity in this parasite.

Authors:  Franklin Souza-Silva; Saulo Cabral Bourguignon; Bernardo Acácio Santini Pereira; Luzia Monteiro de Castro Côrtes; Luiz Filipe Gonçalves de Oliveira; Andrea Henriques-Pons; Lea Cysne Finkelstein; Vitor Francisco Ferreira; Paula Fernandes Carneiro; Rosa Teixeira de Pinho; Ernesto Raul Caffarena; Carlos Roberto Alves
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

Review 6.  Primary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and Treatment.

Authors:  Dmitriy M Niyazov; Stephan G Kahler; Richard E Frye
Journal:  Mol Syndromol       Date:  2016-06-03

Review 7.  Anesthetic Management of a Child With Unspecified Mitochondrial Disease in an Outpatient Dental Setting.

Authors:  Taylor R Gordon; Richard J Montandon
Journal:  Anesth Prog       Date:  2017

8.  6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson's disease: respirometric, histological, and behavioral analyses.

Authors:  Andreas Kupsch; Werner Schmidt; Zemfira Gizatullina; Grazyna Debska-Vielhaber; Jürgen Voges; Frank Striggow; Patricia Panther; Herbert Schwegler; Hans-Jochen Heinze; Stefan Vielhaber; Frank Norbert Gellerich
Journal:  J Neural Transm (Vienna)       Date:  2014-03-14       Impact factor: 3.575

Review 9.  The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence.

Authors:  F Ferrari; R F Villa
Journal:  Mol Neurobiol       Date:  2016-08-10       Impact factor: 5.590

Review 10.  Placental mitochondrial dysfunction with metabolic diseases: Therapeutic approaches.

Authors:  Jessica F Hebert; Leslie Myatt
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-09-10       Impact factor: 5.187

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.